New diagnostic biomarker is used to identify patients at risk for cerebral aneurysm risk at a very early stage. The newly discovered maladaptive cerebrovascular remodeling genes enables the development of biomarkers.
from Medindia Health News https://ift.tt/2LsuJSh
No comments:
Post a Comment